Star Combo Pharma Ltd Cash Flow Conversion Efficiency
Star Combo Pharma Ltd cash flow conversion efficiency. Based on the latest financial reports, Star Combo Pharma Ltd (S66) has a cash flow conversion efficiency ratio of 0.015x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$575.23K ≈ $407.01K USD) by net assets (AU$38.68 Million ≈ $27.37 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Star Combo Pharma Ltd (2016–2025)
Cash flow conversion efficiency of Star Combo Pharma Ltd from 2016 to 2025. This chart illustrates how Star Combo Pharma Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Star Combo Pharma Ltd (S66) share price today for real-time trading data and today's change.
Star Combo Pharma Ltd Cash Flow Conversion Ratio Explained
Star Combo Pharma Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Star Combo Pharma Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Star Combo Pharma Ltd ranked by their cash flow conversion efficiency. Also see S66 company net worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
YBM Net Inc
KQ:057030
|
-0.008x |
|
Moatech Co. Ltd
KQ:033200
|
0.005x |
|
Pointerra Ltd
AU:3DP
|
2.015x |
|
The Western India Plywoods Limited
NSE:WIPL
|
0.093x |
|
Maha Rashtra Apex Corporation Limited
NSE:MAHAPEXLTD
|
-0.003x |
|
System1 Inc
NYSE:SST
|
-0.611x |
|
Cytosorbents Crp
NASDAQ:CTSO
|
2.324x |
|
BBI Development S.A.
WAR:BBD
|
0.056x |
Annual Cash Flow Conversion Efficiency for Star Combo Pharma Ltd (2016–2025)
The table below shows the annual cash flow conversion efficiency of Star Combo Pharma Ltd from 2016 to 2025. Review S66 cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | AU$38.26 Million ≈ $27.07 Million |
AU$11.94 Million ≈ $8.45 Million |
0.312x | +3404.96% |
| 2024-06-30 | AU$33.51 Million ≈ $23.71 Million |
AU$-316.45K ≈ $-223.91K |
-0.009x | -116.74% |
| 2023-06-30 | AU$33.26 Million ≈ $23.53 Million |
AU$1.88 Million ≈ $1.33 Million |
0.056x | +2193.37% |
| 2022-06-30 | AU$35.41 Million ≈ $25.05 Million |
AU$87.11K ≈ $61.64K |
0.002x | -73.14% |
| 2021-06-30 | AU$36.19 Million ≈ $25.61 Million |
AU$331.53K ≈ $234.58K |
0.009x | +140.03% |
| 2020-06-30 | AU$44.50 Million ≈ $31.49 Million |
AU$-1.02 Million ≈ $-720.42K |
-0.023x | +79.06% |
| 2019-06-30 | AU$20.00 Million ≈ $14.15 Million |
AU$-2.19 Million ≈ $-1.55 Million |
-0.109x | +3.35% |
| 2018-06-30 | AU$16.26 Million ≈ $11.50 Million |
AU$-1.84 Million ≈ $-1.30 Million |
-0.113x | -290.16% |
| 2017-06-30 | AU$15.68 Million ≈ $11.10 Million |
AU$932.20K ≈ $659.59K |
0.059x | -82.19% |
| 2016-06-30 | AU$3.88 Million ≈ $2.75 Million |
AU$1.30 Million ≈ $917.50K |
0.334x | -- |
About Star Combo Pharma Ltd
Star Combo Pharma Limited manufactures and distributes health food products and nutritional supplements in Australia and China. It operates in two segments, OEM and Retail. The company develops, manufactures, markets, and sells natural health supplements and skin care products. It also provides its products through e-commerce platform to Chinese health product consumers. The company sells its pro… Read more